{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:42:52Z","timestamp":1780522972951,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"The JosefinaMaus and Gabriela Cesarman Chair for Research in Liver Diseases"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jcf.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T23:27:56Z","timestamp":1527290876000},"page":"666-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Primary sclerosing cholangitis is associated with abnormalities in CFTR"],"prefix":"10.1016","volume":"17","author":[{"given":"Steven","family":"Werlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Scotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Uguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Audrezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Yaakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifaat","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Ilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Konikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Galun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai","family":"Slae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Sayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Cohen-Cymberknoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wilschanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Ferec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2018.04.005_bb0005","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.04.005_bb0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","article-title":"Evidence of intestinal inflammation in cystic fibrosis patients","volume":"51","author":"Werlin","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2018.04.005_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MPG.0b013e31824f1516","article-title":"Definitions of pediatric pancreatitis and survey of current clinical practices: report from INSPPIRE (international study group of pediatric pancreatitis in search of a cure)","volume":"55","author":"Morinville","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl. 2","key":"10.1016\/j.jcf.2018.04.005_bb0020","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2018.04.005_bb0025","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.3390\/ijms150813529","article-title":"Cystic fibrosis related liver disease\u2014another black box in hepatology","volume":"15","author":"Staufer","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcf.2018.04.005_bb0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2018.04.005_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cld.2012.11.003","article-title":"Primary sclerosing cholangitis","volume":"17","author":"Zein","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"8","key":"10.1016\/j.jcf.2018.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jcf.2018.04.005_bb0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/BF02282335","article-title":"Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis","volume":"41","author":"McGill","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2018.04.005_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.103.1.52","article-title":"Clinical and genetic risk factors for cystic fibrosis related liver disease","volume":"103","author":"Wilschanski","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2018.04.005_bb0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0168-8278(02)00161-7","article-title":"Cystic fibrosis conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis","volume":"37","author":"Girodon","year":"2002","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jcf.2018.04.005_bb0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","article-title":"Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis","volume":"113","author":"Sheth","year":"2003","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.jcf.2018.04.005_bb0065","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1572-0241.2005.41072.x","article-title":"N Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis","volume":"100","author":"Gallegos-Orozco","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jcf.2018.04.005_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpeds.2007.03.062","article-title":"Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function","volume":"151","author":"Pall","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.jcf.2018.04.005_bb0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2008.07.033","article-title":"Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis","volume":"50","author":"Henckaerts","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2018.04.005_bb0080","article-title":"CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants","author":"Th\u00e8ze","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jcf.2018.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/09031936.01.00092501","article-title":"Nasal potential difference measurements in patients with atypical cystic fibrosis","volume":"17","author":"Wilschanski","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2018.04.005_bb0090","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1378\/chest.06-2975","article-title":"Reproducibility of nasal potential difference measurements in cystic fibrosis","volume":"132","author":"Yaakov","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2018.04.005_bb0095","article-title":"The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: implications for newborn screening","author":"Stafler","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2018.04.005_bb0105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00439-004-1246-z","article-title":"A neural variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype","volume":"116","author":"Clain","year":"2005","journal-title":"Hum Genet"},{"issue":"11","key":"10.1016\/j.jcf.2018.04.005_bb0110","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/humu.22129","article-title":"CFTR mutation combinations producing frequent complex alleles with different clinical and functional outcomes","volume":"33","author":"El-Seedy","year":"2012","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.jcf.2018.04.005_bb0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpeds.2007.05.025","article-title":"What is the role of cystic fibrosis transmembrane conductance regulator dysfunction in primary sclerosing cholangitis?","volume":"151","author":"Black","year":"2007","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2018.04.005_bb0125","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00452.2003","article-title":"Induction of colitis in CFTR\u2212\/\u2212 mice results in bile duct injury","volume":"287","author":"Blanco","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"10.1016\/j.jcf.2018.04.005_bb0130","doi-asserted-by":"crossref","first-page":"G474","DOI":"10.1152\/ajpgi.00055.2012","article-title":"CFTR dysfunction predisposes to fibrotic liver disease in a murine model","volume":"303","author":"Martin","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcf.2018.04.005_bb0135","first-page":"17","article-title":"Assessing the disease \u2013liability of mutations in CFTR. Cystic fibrosis a trilogy of biochemistry, physiology, and therapy","author":"Ferec","year":"2013","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:38:48Z","timestamp":1761601128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318301152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1569199318301152"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.04.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary sclerosing cholangitis is associated with abnormalities in CFTR","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}